RNA - Avidity Biosciences  - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

RNA is currently covered by 7 analysts with an average price target of $45.85. This is a potential upside of $21.94 (91.76%) from yesterday's end of day stock price of $23.91.

Avidity Biosciences 's activity chart (see below) currently has 5 price targets and 36 ratings on display. The stock rating distribution of RNA is 93.33% BUY and 6.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 9.52% with an average time for these price targets to be met of 32.43 days.

Highest price target for RNA is $50, Lowest price target is $18, average price target is $45.85.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 04-Mar-2024. First documented stock forecast 07-Jul-2020.

Currently out of the existing stock ratings of RNA, 28 are a BUY (93.33%), 2 are a HOLD (6.67%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

35

$10.22 (41.24%)

35

1 months 15 days ago

0/8 (0%)

$16.14 (85.58%)

Buy

23

$-1.78 (-7.18%)

23

1 months 21 days ago

2/6 (33.33%)

$4.7 (25.68%)

115

Buy

18

$-6.78 (-27.36%)

5 months 10 days ago

1/3 (33.33%)

$12.52 (228.47%)

112

Buy

30

$5.22 (21.07%)

30

8 months 10 days ago

0/8 (0%)

$20.65 (220.86%)

Buy

20

$10.67 (114.36%)

20

10 months 28 days ago

0/2 (0%)

$7.92 (65.56%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RNA (Avidity Biosciences ) average time for price targets to be met?

On average it took 32.43 days on average for the stock forecasts to be realized with a an average price target met ratio 9.52

Which analyst has the current highest performing score on RNA (Avidity Biosciences ) with a proven track record?

KEAY NAKAE

Which analyst has the current lower performing score on RNA (Avidity Biosciences ) with a proven track record?

YANAN ZHU

Which analyst has the most public recommendations on RNA (Avidity Biosciences )?

Keay Nakae works at CHARDAN CAPITAL and has 7 price targets and 5 ratings on RNA

Which analyst is the currently most bullish on RNA (Avidity Biosciences )?

Steven Seedhouse with highest potential upside - $46.22

Which analyst is the currently most reserved on RNA (Avidity Biosciences )?

Joseph Schwartz with lowest potential downside - -$6.78

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?